Allergic rhinitis update and its impact in asthma (ARIA 2008): The Latin American perspective;Actualización de rinitis alérgica y su impacto en el asma (ARIA 2008). La perspectiva latinoamericana

Revista Alergia Mexico

Volumn 56, Issue 2, 2009, Pages 56-63

  Baena Cagnani, Carlos E ^a,b   Solé, Dirceu ^b   González Díaz, Sandra N ^b   Zernotti, Mario E ^a   Sisul, Juan C ^b   Sánchez Borges, Mario ^b   Antonieta Guzmán, María ^b   Ivancevich, Juan C ^b   Cepeda, Alfonso ^b   Rodríguez Pérez, Noel ^b   Gereda, José ^b   Cruz, Alvaro ^b   Croce, Víctor H ^a   Khaltaev, Nikolai ^b   Bousquet, Jean ^b  

^a UNIVERSIDAD CATÓLICA DE CÓRDOBA   (Argentina)

^b NONE   (Argentina)

Author keywords

ARIA; Asthma; Evidences; Guide; Latin America; Rhinits

Indexed keywords

CORTICOSTEROID; DECONGESTIVE AGENT; HISTAMINE H1 RECEPTOR ANTAGONIST; LEUKOTRIENE RECEPTOR BLOCKING AGENT; ANTIALLERGIC AGENT;

ABSENTEEISM; ALLERGIC RHINITIS; ASTHMA; CENTRAL AMERICA; COMORBIDITY; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; HEALTH CARE COST; HUMAN; IMMUNOTHERAPY; OTITIS MEDIA; PRACTICE GUIDELINE; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SINUSITIS; SLEEP DISORDER; SOUTH AMERICA; SYMPTOMATOLOGY; WORKPLACE; ALGORITHM; DEVELOPING COUNTRY; HAY FEVER; ORGANIZATION AND MANAGEMENT; PERENNIAL RHINITIS; PREVALENCE; SOCIOECONOMICS; SOUTH AND CENTRAL AMERICA; WORLD HEALTH ORGANIZATION;

ALGORITHMS; ANTI-ALLERGIC AGENTS; ASTHMA; COMORBIDITY; DEVELOPING COUNTRIES; EVIDENCE-BASED MEDICINE; HUMANS; LATIN AMERICA; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; SOCIOECONOMIC FACTORS; WORLD HEALTH ORGANIZATION;

EID: 77953473250     PISSN: 00025151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. Canonica GW, Bousquet J, Mullol J, Scadding GK, Virchow JC. A survey of the burden of allergic rhinitis in Europe. Allergy 2007;62(Suppl. 85):17-25. (Pubitemid 47561569)
2. van Oene CM, van Reij EJ, Sprangers MA, Fokkens WJ. Quality-assessment of disease-specific quality of life questionnaires for rhinitis and rhinosinusitis: a systematic review. Allergy 2007;62(12):1359-1371 (Pubitemid 350045584)
3. Schatz M. A survey of the burden of allergic rhinitis in the USA. Allergy.2007;62 (Suppl. 85):9-16. (Pubitemid 47561568)
4. Walker S, Khan-Wasti S, Fletcher M, Cullinan P, et al. Seasonal allergic rhinitis is associated with a detrimental effect on examination performance in United Kingdom teenagers: case-control study. J Allergy Clin Immunol 2007;120(2):381-387
5. Maurer M, Zuberbier T. Undertreatment of rhinitis symptoms in Europe: findings from a cross-sectional questionnaire survey. Allergy. 2007;62(9):1057-1063 (Pubitemid 47220961)
6. Bousquet J, Dahl R, Khaltaev N. Global alliance against chronic respiratory diseases. Allergy 2007;62(3):216-223 (Pubitemid 46246495)
7. Bousquet J, Khaltaev N. Global surveillance, prevention and control of chronic respiratory diseases. A comprehensive approach. Global Alliance against Chronic Respiratory Diseases. World Health Organization, 2007;p:148.
8. Asher MI, Montefort S, Bjorksten B, Lai CK, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006;368(9537):733-743 (Pubitemid 44279052)
9. Ait-Khaled N, Odhiambo J, Pearce N, Adjoh KS, et al. Prevalence of symptoms of asthma, rhinitis and eczema in 13- to 14-year-old children in Africa: the International Study of Asthma and Allergies in Childhood Phase III. Allergy 2007;62(3):247-258 (Pubitemid 46246500)
10. Pekkarinen PT, von Hertzen L, Laatikainen T, Makela MJ, et al. A disparity in the association of asthma, rhinitis, and eczema with allergen-specific IgE between Finnish and Russian Karelia. Allergy 2007;62(3):281-287 (Pubitemid 46246485)
11. Majkowska-Wojciechowska B, Pelka J, Korzon L, Kozlowska A, et al. Prevalence of allergy, patterns of allergic sensitization and allergy risk factors in rural and urban children. Allergy 2007;62(9):1044-1050 (Pubitemid 47220976)
12. Viinanen A, Munhbayarlah S, Zevgee T, Narantsetseg L, et al. The protective effect of rural living against atopy in Mongolia. Allergy 2007;62(3):272-280 (Pubitemid 46246488)
13. van Ree R, Yazdanbakhsh M. Allergic disorders in African countries: linking immunology to accurate phenotype. Allergy 2007;62(3):237-246 (Pubitemid 46246502)
14. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(Suppl. 5):S147-334.
15. Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinical guidelines: developing guidelines. BMJ 1999;318(7183):593-596
16. Custovic A, Wijk RG. The effectiveness of measures to change the indoor environment in the treatment of allergic rhinitis and asthma: ARIA update (in collaboration with GA(2) LEN). Allergy 2005;60(9):1112-1115 (Pubitemid 41153135)
17. Passalacqua G, Bousquet PJ, Carlsen KH, Kemp J, et al. ARIA update: I - Systematic review of complementary and alternative medicine for rhinitis and asthma. J Allergy Clin Immunol 2006;117(5):1054-1062
18. Bonini S, Bonini M, Bousquet J, Brusasco V, et al. Rhinitis and asthma in athletes: an ARIA document in collaboration with GA2LEN. Allergy 2006;61(6):681-692 (Pubitemid 43801401)
19. Bousquet J, van Cauwenberge P, Ait Khaled N, Bachert C, et al. Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GALEN). Allergy 2006;61(9):1086-1096 (Pubitemid 44175216)
20. Passalacqua G, Durham SR. Allergic rhinitis and its impact on asthma update: allergen immunotherapy. J Allergy Clin Immunol 2007;119(4):881-891 (Pubitemid 46527840)
21. Cruz AA, Popov T, Pawankar R, Annesi-Maesano I, et al. Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2) LEN. Allergy 2007;62 (Suppl. 84):1-41.
22. Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J 2004;24(5):758-764 (Pubitemid 39504428)
23. Demoly P, Allaert FA, Lecasble M, Bousquet J. Validation of the classification of ARIA (allergic rhinitis and its impact on asthma). Allergy 2003;58(7):672-675 (Pubitemid 36831326)
24. Bachert C, van Cauwenberge P, Olbrecht J, van Schoor J. Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium. Allergy 2006;61(6):693-698 (Pubitemid 43801402)
25. Todo-Bom A, Loureiro C, Almeida MM, Nunes C, et al. Epidemiology of rhinitis in Portugal: evaluation of the intermittent and the persistent types. Allergy 2007;62(9):1038-1043 (Pubitemid 47220975)
26. Van Hoecke H, Vastesaeger N, Dewulf L, De Bacquer D, van Cauwenberge P. Is the allergic rhinitis and its impact on asthma classification useful in daily primary care practice? J Allergy Clin Immunol 2006;118(3):758-759
27. Valero A, Ferrer M, Sastre J, Navarro AM, et al. A new criterion by which to discriminate between patients with moderate allergic rhinitis and patients with severe allergic rhinitis based on the Allergic Rhinitis and its Impact on Asthma severity items. J Allergy Clin Immunol 2007;120(2):359-365
28. Bousquet PJ, Combescure C, Neukirch F, Klossek JM, et al. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy 2007;62(4):367-372 (Pubitemid 46398791)
29. Boot JD, de Kam ML, Mascelli MA, Miller B, et al. Nasal nitric oxide: longitudinal reproducibility and the effects of a nasal allergen challenge in patients with allergic rhinitis. Allergy 2007;62(4):378-384 (Pubitemid 46398806)
30. Juniper EF, Riis B, Juniper BA. Development and validation of an electronic version of the Rhinoconjunctivitis Quality of Life Questionnaire. Allergy 2007;62(9):1091-1093 (Pubitemid 47220962)
31. Nizankowska-Mogilnicka E, Bochenek G, Mastalerz L, Swierczynska M, et al. Aspirin provocation tests for diagnosis of aspirin sensitivity. EAACI/GA2LEN guideline. Allergy 2007;62(10):1111-1118
32. Bonini M, Lapucci G, Petrelli G, Todaro A, et al. Predictive value of allergy and pulmonary function tests for the diagnosis of asthma in elite athletes. Allergy 2007;62(10):1166-1170 (Pubitemid 47374031)
33. Bonini S, Rasi G, Brusasco V, Carlsen KH, et al. Nonspecific provocation of target organs in allergic diseases: EAACI-GA(2)LEN consensus report. Allergy 2007;62(6):683-694
34. Burgess JA, Walters EH, Byrnes GB, Matheson MC, et al. Childhood allergic rhinitis predicts asthma incidence and persistence to middle age: a longitudinal study. J Allergy Clin Immunol 2007;120(4):863-869 (Pubitemid 47531852)
35. Chatkin MN, Menezes AM, Victora CG, Barros FC. High prevalence of asthma in preschool children in Southern Brazil: a population-based study. Pediatr Pulmonol 2003;35(4):296-301. (Pubitemid 36397682)
36. Giovannini M, Agostoni C, Riva E, Salvini F, et al. A randomized prospective double blind controlled trial on effects of long-term consumption of fermented milk containing Lactobacillus casei in pre-school children with allergic asthma and/or rhinitis. Pediatr Res 2007;62:215-220
37. Viegi G, La Grutta S. Rhinoconjunctivitis and wheeze in preschool children: a different relationship than in adults (United or Coexistent Airways Disease)? Allergy 2007;62(4):344-347 (Pubitemid 46398809)
38. Choi SH, Yoo Y, Yu J, Rhee CS, et al. Bronchial hyperresponsiveness in young children with allergic rhinitis and its risk factors. Allergy 2007;62(9):1051-1056 (Pubitemid 47220968)
39. Bateman ED, Jithoo A. Asthma and allergy - a global perspective. Allergy 2007;62(3):213-215
40. English RG, Fairall LR, Bateman ED. Keeping allergy on the agenda: integrated guidelines for respiratory disease in developing countries. Allergy 2007;62(3):224-229
41. Bousquet J, Khaltaev N, Cruz A, Denburg J, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63(Suppl. 86):8-160.
42. Schunemann HJ, Hill SR, Kakad M, Vist GE, et al. Transparent development of the WHO rapid advice guidelines. PLoS Med 2007;4(5):e119. (Pubitemid 46842567)
43. Brozek JL, Baena-Cagnani CE, Bonini S, Canonica GW, et al. Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update. Allergy 2008;63(1):38-46.
44. Fokkens WJ, Jogi R, Reinartz S, Sidorenko I, et al. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen. Allergy 2007;62(9):1078-1084 (Pubitemid 47220983)
45. Philip G, Nayak AS, Berger WE, Leynadier F, et al. The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Curr Med Res Opin 2004;20(10):1549-1558 (Pubitemid 39457543)
46. Barnes ML, Menzies D, Fardon TC, Burns P, et al. Combined mediator blockade or topical steroid for treating the unified allergic airway. Allergy 2007;62(1):73-80. (Pubitemid 44902738)
47. Durham SR, Riis B. Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockage. Allergy 2007;62(8):954-957 (Pubitemid 47037852)
48. Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006;117(4):802-809
49. Dahl R, Kapp A, Colombo G, de Monchy JG, et al. Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006;118(2):434-440 (Pubitemid 44160721)
50. Didier A, Malling HJ, Worm M, Horak F, et al. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol 2007;120(6):1338-1345 (Pubitemid 350225683)
51. Canonica GW, Baena-Cagnani CE, Bousquet J, Bousquet PJ, et al. Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce. Allergy 2007;62(3):317-324
52. Clark J, Schall R. Assessment of combined symptom and medication scores for rhinoconjunctivitis immunotherapy clinical trials. Allergy 2007;62(9):1023-1028 (Pubitemid 47220978)
53. Casale TB, Romero FA, Spierings EL. Intranasal noninhaled carbon dioxide for the symptomatic treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 2008;121:105-109
54. Molgaard E, Thomsen SF, Lund T, Pedersen L, et al. Differences between allergic and nonallergic rhinitis in a large sample of adolescents and adults. Allergy 2007;63:1033-1037 (Pubitemid 47220960)
55. Greiner AN, Meltzer EO. Pharmacologic rationale for treating allergic and nonallergic rhinitis. J Allergy Clin Immunol 2006;118(5):985-998 (Pubitemid 44666975)
56. Linneberg A, Jorgensen T, Nielsen NH, Madsen F, et al. The prevalence of skin-test-positive allergic rhinitis in Danish adults: two cross-sectional surveys 8 years apart. The Copenhagen Allergy Study. Allergy 2000;55(8):767-772
57. Terreehorst I, Oosting AJ, Tempels-Pavlica Z, de Monchy JG, et al. Prevalence and severity of allergic rhinitis in house dust mite-allergic patients with bronchial asthma or atopic dermatitis. Clin Exp Allergy 2002;32(8):1160-1165 (Pubitemid 35007417)
58. Georgy V, Fahim HI, El Gaafary M, Walters S. Prevalence and socioeconomic associations of asthma and allergic rhinitis in Cairo, Egypt. Eur Respir J 2006;28:756-762 (Pubitemid 46331996)
59. Kuyucu S, Saraclar Y, Tuncer A, Geyik PO, et al. Epidemiologic characteristics of rhinitis in Turkish children: the International Study of Asthma and Allergies in Childhood (ISAAC) phase 2. Pediatr Allergy Immunol 2006;17(4):269-277 (Pubitemid 43873586)
60. Antonicelli L, Micucci C, Voltolini S, Feliziani V, et al. Allergic rhinitis and asthma comorbidity: ARIA classification of rhinitis does not correlate with the prevalence of asthma. Clin Exp Allergy 2007;37(6):954-960 (Pubitemid 47074560)
61. Antonicelli L, Micucci C, Voltolini S, Senna GE, et al. Relationship between ARIA classification and drug treatment in allergic rhinitis and asthma. Allergy 2007;62(9):1064-1070 (Pubitemid 47220979)
62. Stelmach R, do Patrocinio TNM, Ribeiro M, Cukier A. Effect of treating allergic rhinitis with corticosteroids in patients with mild-to-moderate persistent asthma. Chest 2005;128(5):3140-3147
63. Camargos P, Ibiapina C, Lasmar L, Cruz AA. Obtaining concomitant control of allergic rhinitis and asthma with a nasally inhaled corticosteroid. Allergy 2007;62(3):310-316 (Pubitemid 46246484)
64. Jacobsen L, Niggemann B, Dreborg S, Ferdousi HA, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007;62(8):943-948 (Pubitemid 47037870)
65. Civelek E, Soyer OU, Gemicioglu B, Sekerel BE. Turkish physicians' perception of allergic rhinitis and its impact on asthma. Allergy 2006;61(12):1454-1458 (Pubitemid 44665311)
66. Demoly P, Concas V, Urbinelli R, Allaert F. Evaluation de l'influence des recommandations OMS-ARIA sur la prise en charge de la rhinite allergique en pratique de ville en France. Enguête ERNANI. Rev fr Allergol Immunol Clin 2006;46:626-632
67. ISAAC, International Study of Asthma and Allergies in Children. [en línea]. Dirección URL: 〈http://isaac.auckland.ac.nz/ phaseone/results/results.htlm〉. [Consulta: 10 de septiembre de 2008].
68. Strachan D, Sibbald B, Weiland S, Aït-Khaled N, et al. Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol 1997;8(4):161-176 (Pubitemid 28127720)
69. Strachan DP. Family size, infection and atopy: the first decade of the "hygiene hypothesis". Thorax 2000;55(Suppl. 1):S2-10.
70. Arruda LK, Solé D, Baena-Cagnani CE, Naspitz CK. Risk factors for asthma and atopy. Curr Opin Allergy Clin Immunol 2005;5(2):153-159
71. Björkstén B, Clayton T, Ellwood P, Stewart A, et al. Worldwide time trends for symptoms of rhinitis and conjunctivitis: Phase III of the International Study of Asthma and Allergies in Childhood. Pediatr Allergy Immunol 2008;19(2):110-124
72. Baena-Cagnani CE, Patiño CM, Cuello MN, Minervini MC, et al. Prevalence and severity of asthma and wheezing in an adolescent population. Int Arch Allergy Immunol 1999;118(2-4):245-246 (Pubitemid 29195525)
73. Baena-Cagnani CE, Passalacqua G, Gómez M, Zernotti ME, Canonica GW. New perspectives in the treatment of allergic rhinitis and asthma in children. Curr Opin Allergy Clin Immunol 2007;7(2):201-206
74. Penagos M, Compalati E, Tarantini F, Baena-Cagnani R, et al. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol 2006;97(2):141-148 (Pubitemid 44272577)
75. Nelson HS. Advances in upper airway diseases and allergen immunotherapy. J Allergy Clin Immunol 2007;119(4):872-880 (Pubitemid 46527809)
76. Canonica GW, Passalacqua G. Sublingual immunotherapy in the treatment of adult allergic rhinitis patients. Allergy 2006;61(Suppl. 81):20-23. (Pubitemid 44106975)
77. GARD (Global Alliance for chronic Respiratory Diseases). [en línea]. Dirección URL: 〈www.who.int/respiratory/gard/.〉. [Consulta: 12 de septiembre de 2008].